HK1076461A1 - Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives - Google Patents

Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives

Info

Publication number
HK1076461A1
HK1076461A1 HK05108415A HK05108415A HK1076461A1 HK 1076461 A1 HK1076461 A1 HK 1076461A1 HK 05108415 A HK05108415 A HK 05108415A HK 05108415 A HK05108415 A HK 05108415A HK 1076461 A1 HK1076461 A1 HK 1076461A1
Authority
HK
Hong Kong
Prior art keywords
fused
trans
preparation
dibenzoä3
büfuran
Prior art date
Application number
HK05108415A
Other languages
English (en)
Inventor
Yolande Lydia Lang
Bart Petrus Anna Maria Medaer
Georges Joseph Corne Hoornaert
Thierry Brossette
Frans Josef Cornel Compernolle
Michel Joseph Mauric Guillaume
Hua Mao
Tomasz Kozlecki
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1076461A1 publication Critical patent/HK1076461A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK05108415A 2001-12-07 2005-09-23 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives HK1076461A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204961 2001-12-07
PCT/EP2002/013560 WO2003048146A1 (en) 2001-12-07 2002-12-02 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES

Publications (1)

Publication Number Publication Date
HK1076461A1 true HK1076461A1 (en) 2006-01-20

Family

ID=8181460

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108415A HK1076461A1 (en) 2001-12-07 2005-09-23 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives

Country Status (21)

Country Link
US (2) US6998494B2 (zh)
EP (1) EP1456193B1 (zh)
JP (1) JP4516752B2 (zh)
KR (1) KR20050044329A (zh)
CN (1) CN1293066C (zh)
AT (1) ATE294168T1 (zh)
AU (1) AU2002342926B2 (zh)
BR (1) BR0214068A (zh)
CA (1) CA2468038C (zh)
DE (1) DE60203937T2 (zh)
ES (1) ES2242076T3 (zh)
HK (1) HK1076461A1 (zh)
HR (1) HRP20040490A2 (zh)
HU (1) HUP0402152A3 (zh)
IL (1) IL162349A0 (zh)
MX (1) MXPA04005400A (zh)
NO (1) NO20042884L (zh)
NZ (1) NZ532806A (zh)
PL (1) PL369585A1 (zh)
WO (1) WO2003048146A1 (zh)
ZA (1) ZA200404394B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998494B2 (en) * 2001-12-07 2006-02-14 Janssen Pharmaceutica N.V. Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
AU2005251948A1 (en) * 2004-06-14 2005-12-22 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives
JP2008511582A (ja) * 2004-08-31 2008-04-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ［２−（４−フルオロ−ベンジル）−フェニル］−酢酸の製造方法
JP4912320B2 (ja) 2004-12-07 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換された四環式テトラヒドロピラン、ピロリジンおよびテトラヒドロチオフェン誘導体
US7915249B2 (en) 2005-01-27 2011-03-29 Janssen Pharmaceutical Nv Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders
KR101299518B1 (ko) 2005-06-17 2013-08-29 얀센 파마슈티카 엔.브이. 사이클릭 아민 측쇄를 함유한 신규한 테트라사이클릭테트라하이드로푸란 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123655A (en) * 1996-04-12 2001-03-19 Janssen Pharmaceutica Nv Substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical compositions containing them
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
KR20050044334A (ko) * 2001-12-07 2005-05-12 얀센 파마슈티카 엔.브이. 시스-융합된3,3ａ,8,12ｂ-테트라하이드로-2Ｈ-디벤조[3,4:6,7]사이클로헵타[1,2-ｂ]푸란 유도체의 제조
US6998494B2 (en) * 2001-12-07 2006-02-14 Janssen Pharmaceutica N.V. Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives

Also Published As

Publication number Publication date
US20050228043A1 (en) 2005-10-13
ES2242076T3 (es) 2005-11-01
DE60203937D1 (de) 2005-06-02
DE60203937T2 (de) 2006-05-11
CN1293066C (zh) 2007-01-03
HUP0402152A2 (hu) 2005-02-28
KR20050044329A (ko) 2005-05-12
WO2003048146A1 (en) 2003-06-12
US6998494B2 (en) 2006-02-14
PL369585A1 (en) 2005-05-02
HRP20040490A2 (en) 2004-10-31
ATE294168T1 (de) 2005-05-15
IL162349A0 (en) 2005-11-20
EP1456193B1 (en) 2005-04-27
NZ532806A (en) 2006-01-27
BR0214068A (pt) 2004-10-13
JP2005511691A (ja) 2005-04-28
HUP0402152A3 (en) 2007-03-28
EP1456193A1 (en) 2004-09-15
CA2468038A1 (en) 2003-06-12
JP4516752B2 (ja) 2010-08-04
MXPA04005400A (es) 2004-10-11
AU2002342926A1 (en) 2003-06-17
AU2002342926B2 (en) 2009-02-26
CA2468038C (en) 2011-04-26
ZA200404394B (en) 2005-09-05
NO20042884L (no) 2004-07-07
CN1602306A (zh) 2005-03-30
US20050014820A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
HK1076461A1 (en) Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives
NZ522568A (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
AUPR213700A0 (en) Antiviral agents
HK1071129A1 (en) Novel compounds
BG105137A (en) Antiparasitic artemisinin derivatives (endoperoxides)
BG105457A (en) Method for the preparation of citalopram
HK1070063A1 (en) Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments
MXPA04000755A (es) Nuevos compuestos.
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
CA2397270A1 (en) Method for the preparation of 5-cyanophthalide
HU895657D0 (en) Process for the preparation of mevalonolactones containing thienopyridine ring and pharmaceutical compositions containing such acitve ingredients
MXPA04005399A (es) Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano.
PL367774A1 (en) Synthesis and intermediates
WO2001056992A3 (en) Dibenzo (b,f) azepine intermediates
AU6220300A (en) Benzofurylpiperazine serotonin agonists
IL145449A0 (en) Processes for preparing pesticidal intermediates
WO2004065360A3 (en) Piperazine derivatives and their use as synthesis intermediates
MXPA02003639A (es) Proceso nuevo para la sintesis de (3as)-5, 5-dioxo-2, 3, 3a-4- tetrahidro-1h-pirrolo[2, 1c][1, 2, 4] benzotiadiazina.
EP1241167A4 (en) DERIVATIVES OF 3-ETHYL-, 3-PROPYL-, OR 3-BUTYL-CHROMANE AND -THIOCHROMANE
MXPA03003466A (es) Derivados de piranosido.
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
CA2323315A1 (en) Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
FI104078B (fi) Menetelmä terapeuttisesti käyttökelpoisten (3-(1-piperatsinyyli)tieno£2,3-b|- ja -£2,3-c|pyridiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101202